NRO — Neurones SA Balance Sheet

0.000.00%

Last trade - 00:00

TechnologyBalancedMid CapHigh Flyer

Annual balance sheet for Neurones SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	174	218	266	265	272
Net Total Accounts Receivable
Net Total Receivables	202	186	176	190	225
Total Inventory
Prepaid Expenses
Total Current Assets	383	413	449	464	507
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	16.2	47.1	46.6	46.1	49.8
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	449	510	550	568	617
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	152	156	161	185	207
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	182	213	227	256	286
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	267	297	323	312	331
Total Liabilities & Shareholders' Equity	449	510	550	568	617
Total Common Shares Outstanding